MAP4

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562545

CAS#: 157381-42-5

Description: MAP4 is a selective group III metabotropic glutamate receptor antagonist in some electrophysiological systems. It also acts as a group II/group III agonist in certain neurochemical systems.

Chemical Structure

img
MAP4
CAS# 157381-42-5
Instruction

Theoretical Analysis

MedKoo Cat#: 562545
Name: MAP4
CAS#: 157381-42-5
Chemical Formula: C5H12NO5P
Exact Mass: 197.05
Molecular Weight: 197.120
Elemental Analysis: C, 30.47; H, 6.14; N, 7.11; O, 40.58; P, 15.71

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: MAP4; MAP-4; MAP 4;

IUPAC/Chemical Name: (S)-2-Amino-2-methyl-4-phosphonobutanoic acid

InChi Key: HONKEGXLWUDTCF-YFKPBYRVSA-N

InChi Code: InChI=1S/C5H12NO5P/c1-5(6,4(7)8)2-3-12(9,10)11/h2-3,6H2,1H3,(H,7,8)(H2,9,10,11)/t5-/m0/s1

SMILES Code: O=C(O)[C@@](C)(N)CCP(O)(O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 197.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Ramkumar A, Jong BY, Ori-McKenney KM. ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins. Dev Dyn. 2018 Jan;247(1):138-155. doi: 10.1002/dvdy.24599. Epub 2017 Oct 27. Review. PubMed PMID: 28980356; PubMed Central PMCID: PMC5739964.

2: Mohan R, John A. Microtubule-associated proteins as direct crosslinkers of actin filaments and microtubules. IUBMB Life. 2015 Jun;67(6):395-403. doi: 10.1002/iub.1384. Epub 2015 Jun 24. Review. PubMed PMID: 26104829.

3: Holmfeldt P, Sellin ME, Gullberg M. Predominant regulators of tubulin monomer-polymer partitioning and their implication for cell polarization. Cell Mol Life Sci. 2009 Oct;66(20):3263-76. doi: 10.1007/s00018-009-0084-5. Epub 2009 Jul 8. Review. PubMed PMID: 19585080.

4: Hait WN, Yang JM. The individualization of cancer therapy: the unexpected role of p53. Trans Am Clin Climatol Assoc. 2006;117:85-101; discussion 101. Review. PubMed PMID: 18528466; PubMed Central PMCID: PMC1500917.

5: McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008 Apr;1785(2):96-132. Epub 2007 Nov 12. Review. PubMed PMID: 18068131.

6: Brown L, Boswell S, Raj L, Lee SW. Transcriptional targets of p53 that regulate cellular proliferation. Crit Rev Eukaryot Gene Expr. 2007;17(1):73-85. Review. PubMed PMID: 17361486.

7: Scholz D, McDermott P, Garnovskaya M, Gallien TN, Huettelmaier S, DeRienzo C, Cooper G 4th. Microtubule-associated protein-4 (MAP-4) inhibits microtubule-dependent distribution of mRNA in isolated neonatal cardiocytes. Cardiovasc Res. 2006 Aug 1;71(3):506-16. Epub 2006 Jun 5. Review. PubMed PMID: 16750521.

8: Dehmelt L, Halpain S. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 2005;6(1):204. Epub 2004 Dec 23. Review. PubMed PMID: 15642108; PubMed Central PMCID: PMC549057.

9: Kumarapeli AR, Wang X. Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol. 2004 Dec;37(6):1097-109. Review. PubMed PMID: 15572040.

10: Andersen SS. Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18. Trends Cell Biol. 2000 Jul;10(7):261-7. Review. PubMed PMID: 10856928.

11: Yamamoto H, Miyamoto E. [Dephosphorylation of cytoskeletal proteins: phosphorylation and dephosphorylation of microtubule proteins]. Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1004-12. Review. Japanese. PubMed PMID: 9655957.

12: MacRae TH. Microtubule organization by cross-linking and bundling proteins. Biochim Biophys Acta. 1992 Nov 20;1160(2):145-55. Review. PubMed PMID: 1445941.